Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Genetic Rare Disease

NCT02034630 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02034630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Genetic Rare Disease
Lead sponsor
Seoul National University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 21, 2014
Completion date
December 31, 2023
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic rare disease